42 results on '"A, Ibañez-Costa"'
Search Results
2. Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response
3. The thrombus proteome in stroke reveals a key role of the innate immune system and new insights associated with its etiology, severity, and prognosis
4. Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features
5. Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors
6. Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool
7. Cortistatin: A new link between the growth hormone/prolactin axis, stress, and metabolism
8. Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker
9. The Molecular Registry of Pituitary Adenomas (REMAH): A bet by Spanish Endocrinology for the future of individualized medicine and translational research
10. El Registro Molecular de Adenomas Hipofisarios (REMAH): una apuesta de futuro de la Endocrinología española por la medicina individualizada y la investigación traslacional
11. Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas
12. Desmopressin test in the diagnosis and follow-up of cyclical Cushing's disease
13. The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells
14. OP0231 MASS CYTOMETRY DATA RECLASSIFY SYSTEMIC AUTOIMMUNE DISEASE PATIENTS IN PHENOTYPICALLY DISTINCTIVE GROUPS
15. Oncogenic role of splicing factor SRSF2/SC35 in pancreatic and prostate adenocarcinomas
16. Dietary fat alters the expression of cortistatin and ghrelin systems in the PBMCs of elderly subjects: Putative implications in the postprandial inflammatory response
17. POS0419 ABERRANT SPLICEOSOME AND ALTERED EXPRESSION OF IFN-RESPONSE RELATED GENES ARE HALLMARKS OF MONOCYTES FROM LUPUS PATIENTS WITH RENAL DISEASE
18. OP0038 SPLICEOSOME ALTERATIONS IN LEUCOCYTES FROM APS, SLE AND SLE+APS PATIENTS ARE CLOSELY RELATED TO THEIR MAIN CLINICAL FEATURES
19. Oncogenic role of splicing factor SRSF2/SC35 in pancreatic and prostate adenocarcinomas
20. THU0234 INFLUENCE OF THE SPLICING MACHINERY DYSREGULATION ON THE PATHOGENESIS OF LUPUS AND THE KIDNEY INVOLVEMENT
21. Subclinical Cardiovascular Risk Signs in Adults with Juvenile Idiopathic Arthritis in Sustained Remission
22. Dysregulation of the RNA surveillance machinery in pancreatic cancer: Searching for novel sources of biomarkers and therapeutic targets.
23. Novel insights to study the potential of the somatostatin system in NETs and NECs
24. OP0292 THE HELPFUL EIGHT: KEY SPLICING MACHINERY ELEMENTS IN LEUKOCYTE SUBSETS MAY IMPROVE THE TYPIFICATION OF THE DISEASE IN RHEUMATOID ARTHRITIS PATIENTS
25. SAT0124 MOLECULAR CHARACTERIZATION OF THE SERUM PROFILE ASSOCIATED TO THE INCREASED CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS PATIENTS. EFFECTS OF BIOLOGICAL DRUGS.
26. SAT0037 INCREASED CARDIOMETABOLIC RISK FACTORS ARE RELATED TO THE ABNORMAL ADIPOCYTOKINE PROFILE AND AUTOIMMUNITY IN RHEUMATOID ARTHRITIS. MODULATION BY TNFALPHA AND IL6R INHIBITORS
27. AB0388 COMPARATIVE EFFECTIVENESS OF RITUXIMAB, TOCILIZUMAB AND TNFI BIOLOGICS IN RHEUMATOID ARTHRITIS PATIENTS. INFLUENCE OF CLINICAL AND INFLAMMATORY PROFILES
28. AB0188 MOLECULAR NETWORKS IN MONOCYTES FROM SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS RELATED TO THEIR PHYSIOPATHOLOGY. MODULATORY EFFECTS OF ANTI-DSDNA ANTIBODIES AND MOLECULAR MECHANISMS UNDERLYING IN VIVOSTATIN TREATMENT
29. SAT0036 IMPACT OF RHEUMATOID ARTHRITIS IN LIVER DAMAGE. INVOLVEMENT OF ANTI-CITRULLINATED PROTEIN ANTIBODIES
30. E‐cadherin expression is associated with somatostatin analogue response in acromegaly
31. A functional role for splicing factor EIF4A3 dysregulation in pancreatic ductal adenocarcinoma
32. The expression profile of telomerase complex components reveals novel prognostic insights in pancreatic ductal adenocarcinoma
33. Splicing machinery dysregulation and its relationship with PDAC aggressiveness
34. FRI0157 Altered expression of the spliceosome components in leukocytes subsets from patients with ankylosing spondylitis: association to disease pathogenesis and therapeutic response
35. Alternative splicing dysregulation in pancreatic neuroendocrine tumors: splicing factor CELF4 is upregulated in PanNETs and is associated with aggressiveness
36. Capítulo 3 - Receptores de somatostatina en tumores hipofisarios
37. Engrailed-2 as a novel biomarker for prostate cancer
38. Molecular Characterization of Growth Hormone-producing Tumors in the GC Rat Model of Acromegaly
39. 275 In1-ghrelin splicing variant is over-expressed in prostate cancer where it increases aggressiveness features
40. Unificación de comunicaciones entre el vehículo y la central empleando el protocolo IPv6
41. P056 - Engrailed-2 as a novel biomarker for prostate cancer
42. Colaboradores
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.